STAT Plus: Pharmalittle: Drug makers build Covid-19 vaccine supply chains; VCs are still spending on biotechs
Hello, everyone, and how are you today? We are doing just fine, thank you, despite the hazy skies and muggy temperatures enveloping the Pharmalot campus. Our solution is to cool off with a hot cup of stimulation. This might sound counter-intuitive, but see what happens and report back to us. What have you got to lose? Meanwhile, here are a few tidbits to get you started on your journey today. We hope all goes well, despite the tumult outside your door. Stay in touch and stay safe. …
Drug makers racing to develop Covid-19 vaccines are already working behind the scenes to build the supply chains needed to deliver their drugs to billions of people as rapidly as possible, The Wall Street Journal says. To serve global demand once a vaccine is approved, a complicated and high-stakes supply chain would kick into gear on a scale that the drug industry has rarely seen. The preparations involve lining up raw materials and factory capacity to manufacture a vaccine in large volumes, and equipment needed to transport many millions of doses at once through distribution channels that will be subject to tight security and temperature controls.
Continue to STAT Plus to read the full story…
